143 related articles for article (PubMed ID: 22222908)
1. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
2. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
4. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates.
Krátký M; Vinšová J; Novotná E; Mandíková J; Trejtnar F; Stolaková J
Molecules; 2013 Mar; 18(4):3674-88. PubMed ID: 23529028
[TBL] [Abstract][Full Text] [Related]
7. New amino acid esters of salicylanilides active against MDR-TB and other microbes.
Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J
Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Activity of Salicylanilides and Their Esters with 4-(Trifluoromethyl)benzoic Acid.
Krátký M; Vinšová J
Molecules; 2012 Aug; 17(8):9426-42. PubMed ID: 22871645
[TBL] [Abstract][Full Text] [Related]
9. Antistaphylococcal activity of novel salicylanilide derivatives.
Mollaghan A; Vinsova J; Imramovsky A; Cotter L; Lucey B; O'Mahony J; Costelloe A; Coffey A
Curr Drug Discov Technol; 2012 Mar; 9(1):39-47. PubMed ID: 21644919
[TBL] [Abstract][Full Text] [Related]
10. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial and antifungal activity of salicylanilide benzoates.
Krátký M; Vinšová J; Buchta V
ScientificWorldJournal; 2012; 2012():290628. PubMed ID: 22666101
[TBL] [Abstract][Full Text] [Related]
13. Salicylanilide acetates: synthesis and antibacterial evaluation.
Vinsova J; Imramovsky A; Buchta V; Ceckova M; Dolezal M; Staud F; Jampilek J; Kaustova J
Molecules; 2007 Jan; 12(1):1-12. PubMed ID: 17693949
[TBL] [Abstract][Full Text] [Related]
14. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.
Krátký M; Vinšová J; Buchta V
Med Chem; 2012 Jul; 8(4):732-41. PubMed ID: 22548336
[TBL] [Abstract][Full Text] [Related]
18. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
[TBL] [Abstract][Full Text] [Related]
19. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
[TBL] [Abstract][Full Text] [Related]
20. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
